About TIT
Vision and Mission
We are continuing to make progress and maximize our potential to become a better pharmaceutical company in the territory for intensive care. We have not only equipped with the well-established antibiotics for moderate to severe infections, but also tried aggressively to explore more good products to fulfill current unmet needs for emergency or intensive care. Meanwhile, we are moving toward the territory of preventive medicine, like vaccine business, to expand our scope of health protection for the general public. We will stand at the leading position with our professional expertise.
In virtue of introducing more brand new or breakthrough medicines for moderate to severe infectious therapies continuously, we can dedicate to becoming the pioneer for the new compound development and disease prevention concurrently. We would like to help all the infected patients or the people under the infection risks so we can facilitate the right products for right patients (people) to block the disease invasions or prevent any unpredictable severe consequences.
We will continue to develop and search for good products based on high quality of standards to assist physicians and medical specialties to fight disease since we are always the best partner of the medical professionals. We will stand by physicians to try the best and every effort to save the lives of critical ill patients away from the threats of death then the patients would conquer the diseases and win back their health again.
Market Outlook and Expanded Scope
Along with the busy international communications and information exchanges, we are not satisfied with staying in the Taiwan market. Recently, we are expanding our reaches to China and many other countries around the world to introduce our products there. Where ever there are unmet intensive care needs, we will go. We anticipate to provide our products and services to help more domestic and overseas patients with intensive care needs. We would like to leverage our expertise to keep those patients away from the fear of disease mortality threats.
Moreover, we are collaborating with many famous big international pharmaceutical companies to seek for more good products for our people here when we are developing more good products on our own. Seqirus vaccines headquartered in UK, Merck Co. headquartered in US and Asahi Kasei Pharma headquartered in Japan etc. are all our current or past partners for providing good products for our customers. Our missions are to help people to fight critical illnesses and prevent diseases getting worse to win their precious lives back.